Ceribell Stock Market Value
| CBLL Stock | 20.61 0.18 0.88% |
| Symbol | CeriBell |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. Projected growth potential of CeriBell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CeriBell assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CeriBell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CeriBell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CeriBell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
CeriBell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CeriBell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CeriBell.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in CeriBell on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding CeriBell or generate 0.0% return on investment in CeriBell over 90 days. CeriBell is related to or competes with Treace Medical, Orthopediatrics Corp, Standard Biotools, Enhabit, QuantumSi, Varex Imaging, and Butterfly Network. CeriBell is entity of United States. It is traded as Stock on NASDAQ exchange. More
CeriBell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CeriBell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CeriBell upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.84 | |||
| Information Ratio | 0.2076 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (4.90) | |||
| Potential Upside | 6.82 |
CeriBell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CeriBell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CeriBell's standard deviation. In reality, there are many statistical measures that can use CeriBell historical prices to predict the future CeriBell's volatility.| Risk Adjusted Performance | 0.1673 | |||
| Jensen Alpha | 0.7122 | |||
| Total Risk Alpha | 0.5936 | |||
| Sortino Ratio | 0.2566 | |||
| Treynor Ratio | 0.5235 |
CeriBell February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1673 | |||
| Market Risk Adjusted Performance | 0.5335 | |||
| Mean Deviation | 2.64 | |||
| Semi Deviation | 2.35 | |||
| Downside Deviation | 2.84 | |||
| Coefficient Of Variation | 453.76 | |||
| Standard Deviation | 3.51 | |||
| Variance | 12.31 | |||
| Information Ratio | 0.2076 | |||
| Jensen Alpha | 0.7122 | |||
| Total Risk Alpha | 0.5936 | |||
| Sortino Ratio | 0.2566 | |||
| Treynor Ratio | 0.5235 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (4.90) | |||
| Potential Upside | 6.82 | |||
| Downside Variance | 8.06 | |||
| Semi Variance | 5.52 | |||
| Expected Short fall | (3.14) | |||
| Skewness | 0.543 | |||
| Kurtosis | 0.8183 |
CeriBell Backtested Returns
CeriBell is somewhat reliable given 3 months investment horizon. CeriBell secures Sharpe Ratio (or Efficiency) of 0.3, which signifies that the company had a 0.3 % return per unit of risk over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 1.02% are justified by taking the suggested risk. Use CeriBell Mean Deviation of 2.64, risk adjusted performance of 0.1673, and Downside Deviation of 2.84 to evaluate company specific risk that cannot be diversified away. CeriBell holds a performance score of 23 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CeriBell will likely underperform. Use CeriBell treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to analyze future returns on CeriBell.
Auto-correlation | 0.00 |
No correlation between past and present
CeriBell has no correlation between past and present. Overlapping area represents the amount of predictability between CeriBell time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CeriBell price movement. The serial correlation of 0.0 indicates that just 0.0% of current CeriBell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.73 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out CeriBell Correlation, CeriBell Volatility and CeriBell Performance module to complement your research on CeriBell. For more information on how to buy CeriBell Stock please use our How to buy in CeriBell Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
CeriBell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.